43 results
8-K
EX-99.1
MKULQ
Molekule Group, Inc.
16 Aug 23
Molekule Reports Second Quarter 2023 Financial Results
7:15am
to differ include, but are not limited to:
general economic conditions in the markets where we operate;
the impact of the COVID-19 pandemic
424B3
MKULQ
Molekule Group, Inc.
13 Jul 23
Prospectus supplement
4:42pm
of immunocompromised patients to airborne organisms that cause HAIs but also reduce the risk of COVID-19 transmission. Since the beginning of the COVID-19 pandemic, we … (such as the ongoing COVID-19 pandemic), strikes, government action or other reasons beyond our control or the control of our suppliers, manufacturers and business
424B3
yvnh4t589g32mkhazt97
27 Jun 23
Prospectus supplement
9:13am
DEF 14C
7i1jove mios7
2 Jun 23
Information statement
9:00am
PRE 14C
ydhtu8
22 May 23
Preliminary information
9:00am
8-K
EX-99.1
i7tn psqq0a6n3
16 May 23
Molekule Reports First Quarter 2023 Financial Results
7:44am
8-K
udbs17crh2vjb
8 May 23
Entry into a Material Definitive Agreement
7:40pm
8-K
EX-99.2
z2aire
8 May 23
Entry into a Material Definitive Agreement
7:40pm
8-K
EX-99.1
eps57etoob4fmtez
3 May 23
Regulation FD Disclosure
9:20am
425
33b2hy7spw
28 Apr 23
Business combination disclosure
5:27pm
424B3
1xyppdg w875r
20 Dec 22
Prospectus supplement
7:34pm
S-4
5wfq rnnthhy20h1
19 Dec 22
Registration of securities issued in business combination transactions
11:54am